Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
24.16
+0.09 (0.37%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Amphastar Pharmaceuticals Market Cap
Amphastar Pharmaceuticals has a market cap or net worth of $1.15 billion as of April 25, 2025. Its market cap has decreased by -41.59% in one year.
Market Cap
1.15B
Enterprise Value
1.58B
1-Year Change
-41.59%
Ranking
Category
Stock Price
$24.16
Market Cap Chart
Since June 25, 2014, Amphastar Pharmaceuticals's market cap has increased from $374.20M to $1.15B, an increase of 207.08%. That is a compound annual growth rate of 10.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 1.15B | -35.76% |
| Dec 31, 2024 | 1.79B | -39.75% |
| Dec 29, 2023 | 2.96B | 118.81% |
| Dec 30, 2022 | 1.35B | 21.52% |
| Dec 31, 2021 | 1.11B | 16.65% |
| Dec 31, 2020 | 955.30M | 5.51% |
| Dec 31, 2019 | 905.40M | -1.31% |
| Dec 31, 2018 | 917.40M | 3.71% |
| Dec 29, 2017 | 884.60M | 4.34% |
| Dec 30, 2016 | 847.80M | 32.34% |
| Dec 31, 2015 | 640.60M | 23.57% |
| Dec 31, 2014 | 518.40M | 38.54% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 768.68B |
| UnitedHealth Group | 388.36B |
| Johnson & Johnson | 371.92B |
| AbbVie | 319.51B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.24B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |